Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

NCT04232293 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04232293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2021
Completion date
June 27, 2025
Enrollment
722 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, nafld, nash